Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied Phenomics
Top Cited Papers
Open Access
- 25 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 165 (9), 1076-1087
- https://doi.org/10.1093/aje/kwk115
Abstract
In anticipation of the sequencing of the human genome and description of the human proteome, the Age, Gene/Environment Susceptibility–Reykjavik Study (AGES–Reykjavik) was initiated in 2002. AGES–Reykjavik was designed to examine risk factors, including genetic susceptibility and gene/environment interaction, in relation to disease and disability in old age. The study is multidisciplinary, providing detailed phenotypes related to the cardiovascular, neurocognitive (including sensory), and musculoskeletal systems, and to body composition and metabolic regulation. Relevant quantitative traits, subclinical indicators of disease, and medical diagnoses are identified by using biomarkers, imaging, and other physiologic indicators. The AGES–Reykjavik sample is drawn from an established population-based cohort, the Reykjavik Study. This cohort of men and women born between 1907 and 1935 has been followed in Iceland since 1967 by the Icelandic Heart Association. The AGES–Reykjavik cohort, with cardiovascular risk factor assessments earlier in life and detailed late-life phenotypes of quantitative traits, will create a comprehensive study of aging nested in a relatively genetically homogeneous older population. This approach should facilitate identification of genetic factors that contribute to healthy aging as well as the chronic conditions common in old age.Keywords
This publication has 35 references indexed in Scilit:
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Familial Risk of Lung Carcinoma in the Icelandic PopulationJAMA, 2004
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal OsteoporosisNew England Journal of Medicine, 2003
- Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and FrailtyAnnual Review of Medicine, 2000
- Incidence and prevalence of recognised and unrecognised myocardial infarction in women The Reykjavik StudyEuropean Heart Journal, 1998
- Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health StudyStroke, 1998
- Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.1997
- Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991— the Reykjavik StudyDiabetic Medicine, 1997
- Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik StudyAnnals of Internal Medicine, 1995